Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin F Cobain

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Surgical Oncology|March 1, 2022
Management of early stage HER2 positive breast cancer and increased implementation of axillary imaging to improve identification of nodal metastasisRachel L McCaffrey, Jessica L Thompson, Rebecca H Oudsema, et al.
Current Psychiatry Reports|December 17, 2024
Psychological Considerations Associated with Lobular Breast CancerJasmine C Walker, Shivali Patel, Erin F Cobain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 TrialCostanza Paoletti, William E Barlow, Erin F Cobain, et al.
Plos One|November 15, 2021
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancerElizabeth P Darga, Emily M Dolce, Fang Fang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 17, 2023
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)Mattias Bergqvist, Adrian Nordmark, Amy Williams, et al.
Leukemia Research|February 15, 2017
Genomic analysis of adult B-ALL identifies potential markers of shorter survivalShiven Patel, Clinton C Mason, Martha J Glenn, et al.
JCI Insight|December 21, 2021
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypesAndrea M Pesch, Nicole H Hirsh, Anna R Michmerhuizen, et al.
JCO Precision Oncology|April 30, 2026
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry StudyErin F Cobain, Michael Rothe, Elizabeth Garrett-Mayer, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Surgical Oncology|March 1, 2022
Management of early stage HER2 positive breast cancer and increased implementation of axillary imaging to improve identification of nodal metastasisRachel L McCaffrey, Jessica L Thompson, Rebecca H Oudsema, et al.
Current Psychiatry Reports|December 17, 2024
Psychological Considerations Associated with Lobular Breast CancerJasmine C Walker, Shivali Patel, Erin F Cobain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 TrialCostanza Paoletti, William E Barlow, Erin F Cobain, et al.
Plos One|November 15, 2021
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancerElizabeth P Darga, Emily M Dolce, Fang Fang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 17, 2023
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)Mattias Bergqvist, Adrian Nordmark, Amy Williams, et al.
Leukemia Research|February 15, 2017
Genomic analysis of adult B-ALL identifies potential markers of shorter survivalShiven Patel, Clinton C Mason, Martha J Glenn, et al.
JCI Insight|December 21, 2021
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypesAndrea M Pesch, Nicole H Hirsh, Anna R Michmerhuizen, et al.
JCO Precision Oncology|April 30, 2026
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry StudyErin F Cobain, Michael Rothe, Elizabeth Garrett-Mayer, et al.
JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Pageof 3